Bogor, West Java (Indonesia Window) – Until the end of August 2021, Indonesia has secured 217,936,360 doses of COVID-19 vaccines, consisting of 153,900,280 doses in bulk and 64,036,080 doses of ready-to-use products.

A press release from the state-owned pharmaceutical company Bio Farma on Wednesday (Sep. 1) stated that in September 2021, Indonesia will receive additional 25 million doses of ready-to-use CoronaVac 2 vaccine, and additional vaccines either through the Covax/Gavi multilateral scheme, bilateral basis and donations from other countries.

So that the total availability of vaccines in Indonesia in September was expected to reach more than 70 million doses.

Reporting by Indonesia Window